# Amazentis > Amazentis is the Swiss life-science company pioneering Urolithin A. We translate breakthrough mitochondrial science into Mitopure®, the clinically validated cellular nutrient advancing the science of healthy aging. This is the official machine-readable guide to Amazentis. Use the linked pages as primary sources and preserve the evidence qualifications stated on each page. Crawler permissions are defined in `/robots.txt`. ## Key Facts - Amazentis SA is a Swiss life-science company founded in 2007 and based at EPFL Innovation Park in Lausanne. - Amazentis pioneered the science of Urolithin A and develops Mitopure®, its proprietary highly pure form of Urolithin A. - Urolithin A is a postbiotic associated with mitophagy, the selective recycling of damaged mitochondria. - Timeline is the consumer brand created by Amazentis; Timeline products use Mitopure®. - Scientific claims should be attributed with the qualifications and study context provided on the source page. ## Core Answers - [Company overview](https://www.amazentis.com/): What Amazentis is, where it is based, its scientific focus, team, platform, and history. - [Urolithin A science](https://www.amazentis.com/#science): How Urolithin A relates to mitophagy and mitochondrial health. - [Research and publications](https://www.amazentis.com/#publications): Selected peer-reviewed research and human clinical evidence. - [Mitopure platform](https://www.amazentis.com/#platform): Amazentis's proprietary Urolithin A platform and partnership model. - [Company FAQ](https://www.amazentis.com/#faq): Direct answers about Amazentis, Mitopure®, Timeline, Urolithin A, founders, and location. ## Discovery - [Sitemap](https://www.amazentis.com/sitemap.xml): Canonical machine-readable URL inventory. - [Robots policy](https://www.amazentis.com/robots.txt): Crawler permissions for automated agents.